GHIT Fund announces new investments: A total of 750 million yen in drugs for malaria and Chagas disease, vaccine for malaria, and diagnostics for TB
The Global Health Innovative Technology (GHIT) Fund announced a total of approximately 750 million yen (US$6.6 million) to invest in six partnerships to develop new lifesaving drugs for malaria and Chagas disease, a vaccine for malaria, and diagnostics for TB.
To read the full announcement, click here.
Source: GHIT Fund